Senior Scientist

The case was approved based on 5 peer-reviewed journal articles in high-impact venues like Nature, Cell, and Science, which amassed 1,359 citations from researchers in over 50 countries. The petitioner also demonstrated significant judging experience with 13 peer reviews and an editorial board position. These metrics satisfied the criteria for original contributions of major significance, scholarly authorship, and judging the work of others.

The petition was approved based on 7 peer-reviewed scientific articles cited 152 times by researchers in 19 countries. The applicant demonstrated extraordinary ability through 49 instances of judging the work of peers and providing 5 letters of recommendation from field experts. Her specific contributions to Immunosignature non-natural sequence peptide microarrays for Valley Fever were highlighted as significant.

The petition was approved based on a record of 17 peer-reviewed articles and 1,210 citations, demonstrating extensive independent reliance by the research community. The petitioner also provided evidence of 13 completed manuscript reviews for respected journals. Approval was further supported by original contributions in structure-guided HIV vaccine design and nucleic acid-based strategies for SARS-CoV-2.

The approval was based on the petitioner's documentation of 11 peer-reviewed journal articles with 190 citations, demonstrating a growing influence in biochemistry. Additionally, the petitioner satisfied the judging criterion by completing at least 40 journal reviews and serving on several editorial boards. The national significance of the work was further validated by support from the National Institutes of Health (NIH).